Cardiometabolic Research Center, Inc.

Ponce, PR 00717

0 studies enrolling now · 2 studies all time

What they study most

Cardiovascular Disease, Hyperlipidemia

Studies at this site

• The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects — Stopped early
• Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular Events — Completed